Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Non-cash Items (2016 - 2017)

Dare Bioscience (DARE) has disclosed Non-cash Items for 5 consecutive years, with $545640.0 as the latest value for Q3 2017.

  • For the quarter ending Q3 2017, Non-cash Items fell 66.32% year-over-year to $545640.0, compared with a TTM value of $545640.0 through Sep 2017, down 66.32%, and an annual FY2016 reading of $1.6 million, up 63.26% over the prior year.
  • Non-cash Items was $545640.0 for Q3 2017 at Dare Bioscience, up from $220497.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $3.2 million in Q1 2014 and bottomed at $7000.0 in Q2 2016.
  • Average Non-cash Items over 5 years is $1.0 million, with a median of $747212.0 recorded in 2015.
  • The sharpest move saw Non-cash Items surged 38331.99% in 2014, then crashed 99.76% in 2015.
  • Year by year, Non-cash Items stood at $7028.0 in 2013, then soared by 38331.99% to $2.7 million in 2014, then plummeted by 62.92% to $1.0 million in 2015, then soared by 63.26% to $1.6 million in 2016, then crashed by 66.63% to $545640.0 in 2017.
  • Business Quant data shows Non-cash Items for DARE at $545640.0 in Q3 2017, $220497.0 in Q2 2017, and $1.9 million in Q1 2017.